Advertisement
Screener

PLx Pharma Winddown Corp. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount

PLx Pharma Winddown Corp. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount

PLx Pharma Winddown Corp. had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $6.60 million as of 2022-09-30, per its 10-Q filed 2022-11-10.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure

us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2022-11-10

  • 2022-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $6.60M.
  • 2022-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $7.70M.
  • 2022-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $9.00M.
  • 2021-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $7.50M.
Period endShare-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
2022-09-30$6.60M
10-Q · filed 2022-11-10
2022-06-30$7.70M
10-Q · filed 2022-08-12
2022-03-31$9.00M
10-Q · filed 2022-05-13
2021-12-31$7.50M
10-K · filed 2022-03-11
2021-09-30$8.50M
10-Q · filed 2021-11-12
2021-06-30$4.40M
10-Q · filed 2021-08-06
2021-03-31$4.40M
10-Q · filed 2021-05-14
2020-12-31$4.80M
10-K · filed 2021-03-12
2020-09-30$1.90M
10-Q · filed 2020-11-13
2020-06-30$2.10M
10-Q · filed 2020-08-14
2020-03-31$2.70M
10-Q · filed 2020-05-15
2019-12-31$2.20M
10-K · filed 2020-03-13
2019-09-30$2.50M
10-Q · filed 2019-11-08
2019-06-30$2.90
10-Q · filed 2019-08-09
2019-03-31$3.10M
10-Q · filed 2019-05-10
2018-12-31$553.42K
10-K · filed 2019-03-08
2018-09-30$600.00K
10-Q · filed 2018-11-09
2018-06-30$700.00K
10-Q · filed 2018-08-10
2018-03-31$1.10M
10-Q · filed 2018-05-11
2017-12-31$1.40M
10-K · filed 2018-03-23
2017-09-30$1.50M
10-Q · filed 2017-11-09
2017-06-30$1.26M
10-Q · filed 2017-08-11